http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102351812-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32622955710a511ff5d89f584662fe2f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64163c04feab7a51f14f6af9358ee60b
publicationDate 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102351812-B
titleOfInvention Methanesulfonic acid cinepazide crystal form III and preparation method thereof
abstract The invention relates to a methanesulfonic acid cinepazide crystal form III and a preparation method thereof, and belongs to the field of chemical pharmaceutics. The water solubility of the prepared methanesulfonic acid cinepazide crystal form III is higher than that of an amorphous material, and the methanesulfonic acid cinepazide crystal form III is particularly suitable for injection, has higher chemical stability than the amorphous material, facilitates production of medicines, and storage and transportation of raw material medicines, improves the safety of the medicines and provides safe guarantee for clinical application of the medicines.
priorityDate 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468375054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID641256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411060862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454054139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71315856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56843046

Total number of triples: 30.